The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line durvalumab plus chemotherapy with or without oleclumab for locally advanced or metastatic triple-negative breast cancer: SYNERGY overall survival and circulating tumor DNA analysis.
 
Elisa Agostinetto
Honoraria - Abscint (Inst); AstraZeneca; Lilly
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abscint; AstraZeneca; AstraZeneca; Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
David Venet
No Relationships to Disclose
 
Paulus Krisanto
No Relationships to Disclose
 
Delphine Loirat
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Immunomedics; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; MSD; Novartis; Pfizer; Roche
 
Philippe Aftimos
Honoraria - Gilead Sciences; Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Deloitte; G1 Therapeutics; Gilead Sciences; Incyte; Lilly; Macrogenics; Menarini; Novartis; Novartis; Radius Health; Roche; Servier
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD Oncology; Pfizer; Roche Belgium
 
Zoe Denis
No Relationships to Disclose
 
Hans Wildiers
Consulting or Advisory Role - Agendia (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); MediMix bv (Inst); Menarini (Inst); Novartis (Inst); NV Hict (Inst); Pfizer (Inst); PSI (Inst); Roche (Inst); Seagen (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst)
 
Nicolaas Van Renne
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Evandro de Azambuja
Honoraria - AstraZeneca; Gilead Sciences; Libbs (Inst); Lilly; MSD Oncology; Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; SeaGen; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca (Inst); Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
(OPTIONAL) Uncompensated Relationships - Belgian Society of Medical Oncology (BSMO); ESMO
 
Anthony Gonçalves
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis (Inst)
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Menarini; mylan
 
Françoise Rothé
No Relationships to Disclose
 
Donatienne Taylor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Exact Sciences; Lilly; MSD; Novartis; Roche/Genentech; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis
 
Michail Ignatiadis
Consulting or Advisory Role - Daichi; Gilead Sciences; Menarini Group; Novartis; Rejuveron senescence therapeutics; Seagen
Research Funding - Inivata (Inst); Natera (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent entitled method for determining sensitivity to a CDK4/6 inh filed the 18 05 16 by Universite Libre de Bruxelles, Application No/Patent No 16170146.1-1403
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); Novartis; Roche (Inst)
 
Tom Van den Mooter
Consulting or Advisory Role - Bayer; MSD
Speakers' Bureau - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Gilead Sciences; GlaxoSmithKline; MSD
 
Francois Duhoux
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Menarini (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Roche; Teva
 
Jean-Luc Canon
Consulting or Advisory Role - BMS Brazil; Daiichi Sankyo; Lilly; Pfizer; Roche
 
Florian Clatot
Honoraria - AstraZeneca; AstraZeneca; BMS; BMS; BMS; Daiichi Sankyo/Astra Zeneca; Merck; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD
Consulting or Advisory Role - BMS; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; MSD; Novartis; Novartis; Nutricia; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; BMS; MSD; Novartis; Novartis; Novartis; Pfizer; Roche
 
Christos Sotiriou
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; CEPHEID; Merck; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - EISAI; Foundation Medicine; Genomic Health; Prime Oncology; Teva
Patents, Royalties, Other Intellectual Property - A companion diagnostic for CDK4/CDK6 inhibitory drugs based on CDK4 Phosphorylation. Which patient to be treated and how. PCT/EP2017/061780; Epigenetic portraits of human Breast Cancer, PCT/EP2012/050836, WO2012/098215
Travel, Accommodations, Expenses - Roche; Roche/Genentech; Roche/Genentech
 
Laurence Buisseret
Consulting or Advisory Role - AstraZeneca (Inst); Domain Therapeutics (Inst); Roche (Inst)
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); Roche (Inst)